α-Synuclein -: Its biological function and role in neurodegenerative diseases

被引:40
作者
Kaplan, B [1 ]
Ratner, V
Haas, E
机构
[1] Chaim Sheba Med Ctr, Heller Inst Med Res, IL-52621 Tel Hashomer, Israel
[2] Bar Ilan Univ, Dept Life Sci, IL-52900 Ramat Gan, Israel
关键词
amyloid beta; alpha-synuclein; Alzheimer's disease; Lewy bodies; Parkinson's disease; synucleinopathy;
D O I
10.1385/JMN:20:2:83
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein is regarded as a presynaptic protein, which may play an important role in neuronal plasticity. However, the actual physiological function of this protein is not completely clear. Abnormal accumulation of fibrillar alpha-synuclein in Lewy bodies, as well as mutations in the alpha-synuclein gene identified in the familial forms of Parkinson's disease, point to a central role of this protein in the pathophysiology of Lewy body-related disorders. In vivo and in vitro studies showed that overexpression of alpha-synuclein, its aggregation, and interaction with other proteins are the most critical factors affecting the survival of neurons. In Alzheimer's disease, the amount of alpha-synuclein is found to be elevated at synapses, whereas a peptide derived from alpha-synuclein is thought to represent an intrinsic component of amyloid plaques. It is likely that in this disorder alpha-synuclein plays a dual role by being involved not only in synaptic function but also in amyloid beta-fibrillogenesis.
引用
收藏
页码:83 / 92
页数:10
相关论文
共 93 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   A-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells [J].
Ahn, BH ;
Rhim, H ;
Kim, SY ;
Sung, YM ;
Lee, MY ;
Choi, JY ;
Wolozin, B ;
Chang, JS ;
Lee, YH ;
Kwon, TK ;
Chung, KC ;
Yoon, SH ;
Hahn, SJ ;
Kim, MS ;
Jo, YH ;
Min, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12334-12342
[3]   Tubulin seeds α-synuclein fibril formation [J].
Alim, MA ;
Hossain, MS ;
Arima, K ;
Takeda, K ;
Izumiyama, Y ;
Nakamura, M ;
Kaji, H ;
Shinoda, T ;
Hisanaga, S ;
Uéda, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :2112-2117
[4]   Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein [J].
Arawaka, S ;
Saito, Y ;
Murayama, S ;
Mori, H .
NEUROLOGY, 1998, 51 (03) :887-889
[5]   Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Hirai, S ;
Izumiyama, Y ;
Tonozuka-Uehara, H ;
Kawai, M .
BRAIN RESEARCH, 1998, 808 (01) :93-100
[6]  
Barbieri S, 2001, ADV EXP MED BIOL, V487, P147
[7]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[8]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[9]   Synthetic filaments assembled from C-terminally truncated α-synuclein [J].
Crowther, RA ;
Jakes, R ;
Spillantini, MG ;
Goedert, M .
FEBS LETTERS, 1998, 436 (03) :309-312
[10]   Stabilization of α-synuclein secondary structure upon binding to synthetic membranes [J].
Davidson, WS ;
Jonas, A ;
Clayton, DF ;
George, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9443-9449